Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii
Open Access
- 1 July 2014
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (7), 4172-4179
- https://doi.org/10.1128/aac.02992-14
Abstract
The role of Acinetobacter nosocomialis and Acinetobacter pittii , which belong to the A. calcoaceticus - A. baumannii complex, in hospital-acquired infections is increasingly recognized. Here we describe a retrospective cohort study of hospital-acquired A. calcoaceticus - A. baumannii complex infections at a university hospital in Thailand. A total of 222 unique cases were identified between January 2010 and December 2011. The genomospecies of the A. calcoaceticus - A. baumannii complex isolates were classified as follows: A. baumannii , 197 (89%); A. nosocomialis , 18 (8%); and A. pittii , 7 (3%). All A. nosocomialis and A. pittii isolates were susceptible to imipenem and meropenem. The patients infected with A. nosocomialis and A. pittii had lower 30-day mortality than those infected with carbapenem-susceptible A. baumannii ( P = 0.025) and carbapenem-resistant A. baumannii ( P = 0.013). The factors influencing 30-day mortality were infection with non- baumannii A. calcoaceticus - A. baumannii complex (hazard ratio [HR], 0.12; 95% confidence interval [CI], 0.03 to 0.51; P = 0.004), infection with carbapenem-resistant A. baumannii (HR, 1.57; 95% CI, 0.89 to 2.79; P = 0.105), appropriate empirical antimicrobial therapy (HR, 0.38; 95% CI, 0.23 to 0.61; P < 0.001), and higher acute physiology and chronic health evaluation II (APACHE II) score (HR, 1.15; 95% CI, 1.10 to 1.19; P < 0.001). In Galleria mellonella assays, the survival rates were significantly higher for the larvae infected with A. nosocomialis or A. pittii than for those infected with either carbapenem-susceptible A. baumannii or carbapenem-resistant A. baumannii , but no differences in survival rates were observed between carbapenem-susceptible A. baumannii and carbapenem-resistant A. baumannii . These findings suggest intrinsic differences in virulence between non- baumannii A. calcoaceticus - A. baumannii complex species and A. baumannii but not between carbapenem-susceptible and resistant A. baumannii .Keywords
This publication has 22 references indexed in Scilit:
- The Clinical Characteristics, Carbapenem Resistance, and Outcome of Acinetobacter Bacteremia According to GenospeciesPLOS ONE, 2013
- Emergence of Carbapenem-Resistant Non-baumannii Species of Acinetobacter Harboring a bla OXA-51 -Like Gene That Is Intrinsic to A. baumanniiAntimicrobial Agents and Chemotherapy, 2012
- Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South KoreaInternational Journal of Antimicrobial Agents, 2012
- Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomesJournal of Antimicrobial Chemotherapy, 2011
- Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU)Research in Microbiology, 2011
- Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from NorwayJournal of Antimicrobial Chemotherapy, 2011
- Galleria mellonella as a Model System To Study Acinetobacter baumannii Pathogenesis and TherapeuticsAntimicrobial Agents and Chemotherapy, 2009
- Acinetobacter baumannii : Emergence of a Successful PathogenClinical Microbiology Reviews, 2008
- Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment OptionsClinical Infectious Diseases, 2008
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988